Assessment of the pre-emptive effect of photobiomodulation in the postoperative period of impacted lower third molar extractions: A randomized, controlled, double-blind study protocol

Photobiomodulation is a safe option for controlling pain, edema, and trismus when applied postoperatively in third molar surgery. However, administration prior to surgery has been under-explored. This study aims to explore the effectiveness of pre-emptive photobiomodulation in reducing postoperative...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 19; no. 6; p. e0300136
Main Authors Salaberry, Daniel Rodríguez, Bruno, Laura Hermida, Cirisola, Rolf Wilhem Consolandich, Longo, Priscila Larcher, Chavantes, Maria Cristina, Navarro, Ricardo Scarparo, Gonçalves, Marcela Letícia Leal, Sobral, Ana Paula Taboada, Gimenez, Thais, Duran, Cinthya Cosme Gutierrez, Motta, Lara Jansiski, Bussadori, Sandra Kalil, Horliana, Anna Carolina Ratto Tempestini, Mesquita Ferrari, Raquel Agnelli, Fernandes, Kristianne Porta Santos
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 17.06.2024
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Photobiomodulation is a safe option for controlling pain, edema, and trismus when applied postoperatively in third molar surgery. However, administration prior to surgery has been under-explored. This study aims to explore the effectiveness of pre-emptive photobiomodulation in reducing postoperative edema in impacted lower third molar extractions. Two groups of healthy individuals undergoing tooth extraction will be randomly assigned: Control group receiving pre-emptive corticosteroid and simulated photobiomodulation, and Photobiomodulation Group receiving intraoral low-intensity laser and extraoral LED cluster application. The primary outcome will be postoperative edema after 48 h. The secondary outcomes will be pain, trismus dysphagia, and analgesic intake (paracetamol). These outcomes will be assessed at baseline as well as two and seven days after surgery. Adverse effects will be recorded. Data will be presented as means ± SD and a p-value < 0.05 will be indicative of statistical significance.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Feature-3
ObjectType-Evidence Based Healthcare-1
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
LHB, RWCC, PLL, MCC, RSN, MLLC, APTS, TG, CCGD, LJM, and SKB, also contributed equally to this work.
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0300136